HERC2P5: A Potential Drug Target for Cancer Treatment (G388254)

Target Name: HERC2P5

NCBI ID: G388254

HERC2P5

Other Name(s): D16F37S6 | HERC2 pseudogene 5 | Hect domain and RLD 2 pseudogene 5

HERC2P5: A Potential Drug Target for Cancer Treatment

HERC2P5 (D16F37S6), a protein located on the surface of certain cancer cells, has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study and develop new treatments.

HERC2P5 is a transmembrane protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and liver. It is a member of the HEKOMER family, which is known for its role in cell signaling and interactions. HERC2P5 plays a crucial role in the development and maintenance of the blood-brain barrier, which is a barrier that separates the brain from the rest of the body and helps to protect it from harmful substances.

One of the most significant functions of HERC2P5 is its role in cell signaling. It is a critical regulator of the T-cell receptor, which is responsible for cell signaling and immunity. HERC2P5 has been shown to play a crucial role in the development and maintenance of T-cell receptor function, by regulating the structure and function of the T-cell receptor.

In addition to its role in cell signaling, HERC2P5 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of cancer. For example, studies have shown that HERC2P5 is involved in the regulation of cell cycle progression, and that it plays a role in the development of cancer cells.

The potential drug target status of HERC2P5 is due to its unique structure and function. Its transmembrane structure and its role in cell signaling make it an attractive target for small molecules, antibodies, or other therapeutic agents that can modulate its function and activity. Additionally, its role in the regulation of cellular processes that are important for cancer development makes it an attractive target for drugs that can inhibit its function and prevent the growth and spread of cancer cells.

In conclusion, HERC2P5 is a protein that has the potential to be a drug target or biomarker for the treatment of various diseases, including cancer. Its unique structure and function make it an attractive target for small molecules, antibodies, or other therapeutic agents that can modulate its function and activity. Further research is needed to fully understand the role of HERC2P5 in cell signaling and its potential as a drug target or biomarker.

Protein Name: HERC2 Pseudogene 5

The "HERC2P5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HERC2P5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets